Ultragenyx Pharmaceutical Inc. buy Canaccord Genuity Group Inc.
Start price
20.08.26
/
50%
€21.69
Target price
20.08.27
€71.06
Performance (%)
0.00%
Price
20.08.26
€25.00
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr is currently unchanged from the start price. This prediction currently runs until 20.08.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Ultragenyx Pharmaceutical Inc. | 0.00% |
| iShares Core DAX® | -1.586% |
| iShares Nasdaq 100 | -4.148% |
| iShares Nikkei 225® | -6.302% |
| iShares S&P 500 | -3.225% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (RARE) had its price target raised by Canaccord Genuity Group Inc. from $81.00 to $83.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€17.40
18.02.26
18.02.26
€66.69
18.02.27
18.02.27
24.66%
20.08.26
20.08.26
